Global Soft Tissue Allografts Market to be Driven by Increasing Aging Population and High Incidence Rate of Soft Tissue Injury

The soft tissue allografts market is the largest contributor towards the overall allografts market and is expected to grow progressively over the next few years. An allograft is a graft of tissue obtained from genetically dissimilar donors of the same species. Human soft tissue and bone allografts are being increasingly employed in various orthopedic and general surgical procedures.

According to the Musculoskeletal Transplant Foundation, it has been estimated that almost 900,000 allografts are used each year in the U.S. Admirable product quality supported by successful clinical trials has increased patient preference and surgeon’s confidence to allograft option. The major benefit of soft tissue allografts is vast product differentiation or flexibility to choose from a vast range of appropriate grafts and the ability to customize the grafts according to the patient’s need.

Download Free Sample Research Report: http://bit.ly/2bmKHMe

Standard soft tissue allografts provide various advantages such as lesser surgical time; reduced pain and improved rate of success due to which surgeons as wells as patients prefer these grafts for their treatment. Although disease transmission by an allograft is rare, it can be devastating and fatal. Various organizations such as the American Academy of Orthopedic Surgeons (AAOS) strongly recommend its members to use only tissue from banks that have been strictly inspected by authorities such as the U.S FDA and the American Association of Tissue Banks (AATB).

Geographically, North America accounts for the largest share in the soft tissue allografts market owing to the rising aging population and high adoption rate of advance medical technologies. Europe closely follows North America in terms of market share and is expected to witness a sluggish growth due to the economic turbulence faced by the countries in Western European region. However, other regions such as Asia-Pacific and Latin America are expected to be the potential markets in the near future.

Due to the growing number of health care facilities coupled with high awareness rate among population for innovative surgical procedures, these regions are estimated to be the potential markets. Moreover, high competition and economic slowdown in mature countries such as the U.S., Canada, France and Germany will compel the organizations to focus on the Asia-Pacific market.

The primary factors contributing to the growth of the global soft tissue allografts market are increasing aging population and high incidence rate of soft tissue injury as well as sports injuries. Moreover, increasing prevalence and incidence rate of degenerative joint diseases coupled with growing demand for minimally invasive orthopedic surgical procedures are also driving the growth of the soft tissue allografts market. Furthermore, increased rate of obesity among population are contributing to the growth the overall soft tissue allografts market. However, restraining factors such as increased healthcare expenditure, rising cost of surgical procedures and stringent reimbursement policies by insurers might impede the growth of the soft tissue allografts market.

At present, the global soft tissue allografts market is highly fragmented. Some of the major companies involved with the soft tissue allografts market are AlloSource, Arthrex, Inc., B. Braun Melsungen AG, Covidien plc, Cook Medical, Inc., CONMED Corporation, CorMatrix Cardiovascular, Inc., Ethicon, Inc., Genzyme Corporation, RTI Surgical, Inc., Smith & Nephew plc, Stryker Corporation, TEI Biosciences, Inc and Zimmer Holdings, Inc.

Browse Full Research Report: http://bit.ly/2bqyQBh

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.